![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Hans-Christoph Diener, Sophia Stanford, Azmil Abdul-Rahim, Louisa Christensen, Kristina Dupont Hougaard, Ameet Bakhai, Roland Veltkamp & Hans Worthmann. (2014) Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage. Expert Review of Neurotherapeutics 14:9, pages 1019-1028.
Read now
Read now
Articles from other publishers (6)
Jan C. Purrucker, Peter A. Ringleb & Timolaos Rizos. (2015) Sekundärprophylaxe mit oralen Antikoagulanzien. DNP - Der Neurologe und Psychiater 16:12, pages 36-43.
Crossref
Crossref
Solveig Horstmann, Timolaos Rizos, Michaela Saribas, Evdokia Efthymiou, Geraldine Rauch & Roland Veltkamp. (2015) Cognitive Impairment Is Not a Predictor of Failure to Adhere to Anticoagulation of Stroke Patients with Atrial Fibrillation. Cerebrovascular Diseases 39:5-6, pages 325-331.
Crossref
Crossref
Gregory Y.H. Lip, Lars H. Rasmussen, S. Bertil Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Ulf Eriksson & Karin Wåhlander. (2011) Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapy. Thrombosis Research 127:2, pages 91-99.
Crossref
Crossref
Håkan Walfridsson, Birgitta Johansson, Anders Englund, Göran Kennebäck, Jonas Schwieler, Ole Kongstad, Karin Wåhlander, Anders R. Malm & Nils Edvardsson. (2010) Effects of AZD0837, a Novel Direct Thrombin Inhibitor, on the Electrophysiological Properties of the Human Heart. Clinical Drug Investigation 30:7, pages 461-471.
Crossref
Crossref
Carina Carnlöf, Per Insulander, Pia Holmér Pettersson, Mats Jensen-Urstad & Bjöörn Fossum. (2010) Health-Related Quality of Life in Patients with Atrial Fibrillation Undergoing Pulmonary Vein Isolation, Before and After Treatment. European Journal of Cardiovascular Nursing 9:1, pages 45-49.
Crossref
Crossref
G. Y.H. Lip, L. H. Rasmussen, S. B. Olsson, E. C. Jensen, A. L. Persson, U. Eriksson & K. F.C. Wahlander. (2009) Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. European Heart Journal 30:23, pages 2897-2907.
Crossref
Crossref